Using the mEERL system, we recently reported the ability of the mTOR inhibitor, rapamycin (sirolimus), to enhance CRT-induced cytotoxicity and attenuate tumor metabolism, contributing to improved immune-mediated clearance of HPV+ OPSCC [13]. Here, MTOR is linked to neoplasm.